According to a recent study (2018), GHK-Cu (the first generation of copper peptides) "has multiple biological actions, all of which appear to be health positive
Conversely, a more recent 16-week randomized controlled trial ( n = 58) reported that sulforaphane (approximately 45 mg/day) failed to change the severity of psychotic symptoms compared to placebo using the total Positive and Negative Syndrome Scale (McGuinness and Kim, 2020)
[62], suffered from missing data, which may have affected the reliability of the findings
For more information or to schedule an consultation, click here, contact us at (480) 571-5934 or email info@primedirecthealth@com.
doi: 10.2903/j.efsa.2017.4972
May Aid in Dealing with Autism Spectrum Disorders Some evidence indicates children with autism spectrum disorder suffer from low levels of glutathione compared to peers without the disorder